Defendant Name: Amyris, Inc.

Defendant Type: Public Company
SIC Code: 9999
CUSIP: 03236M20

Initial Case Details

Legal Case Name In the Matter of Amyris, Inc.
First Document Date 15-Oct-2021
Initial Filing Format Administrative Action
File Number 3-20624
Allegation Type Issuer Reporting and Disclosure

Violations Alleged

Exchange Act
Sec 13(a)
Rule 13a-11
Rule 13a-13
Sec 13(b)(2)(A)
Sec 13(b)(2)(B)


First Resolution Date 15-Oct-2021
Headline Total Penalty and Disgorgement

See Related Documents

Related Documents:

34-93341 15-Oct-2021 Administrative Proceeding
Order Instituting Cease-and-Desist Proceedings Pursuant to Section 21C of the Securities Exchange Act of 1934, Making Findings, and Imposing a Cease-and-Desist Order.
On October 15, 2021, the SEC instituted settled cease-and-desist proceedings against Amyris Inc. stating: "During the first two quarters of 2018, Amyris improperly recognized certain royalty revenues that rendered its financial statements materially inaccurate. These revenue recognition errors resulted from internal accounting control failures that led to important information not being communicated to the company’s internal accounting staff concerning certain significant royalty payments, which also resulted in Amyris’s failure to make and keep accurate books and records."
34-93341-s 15-Oct-2021 Administrative Summary
SEC Charges Amyris with Improper Revenue Recognition Resulting from Internal Accounting Control Failures
The SEC "announced settled charges against Amyris, Inc., a San Francisco Bay-Area chemical products developer, for materially overstating its royalty revenues and related internal accounting controls violations."